Wed February 8, 2006
Decision-making in Early Drug Development
SEE EVENT DETAILS
at Kirkpatrick & Lockhart Nicholson Graham LLP
(see times)
Arndt Schottelius, MD, PhD, Director Non-Clinical Drug Development, Genentech will provide insights to the decision making essential in taking a drug candidate from the research lab to drug development. Steps such as cost and risk analysis are discussed for making these crucial decisions on promising future cures.
A panel consisting of representatives of a Venture Capitalist, Jerini, a German Biotech company, and other local Bay Area Biotech companies will be discussing their criteria for funding drug development, presenting their process and expertise. This will provide some lively discussion post presentation.
Complimentary appetizers and drinks will be served.
GABA is a member-driven non-profit organization that fosters transatlantic knowledge-sharing and networking among German-American and Californian business and tech communities through an online corporate database and 10-15 annual business events.
show less
A panel consisting of representatives of a Venture Capitalist, Jerini, a German Biotech company, and other local Bay Area Biotech companies will be discussing their criteria for funding drug development, presenting their process and expertise. This will provide some lively discussion post presentation.
Complimentary appetizers and drinks will be served.
GABA is a member-driven non-profit organization that fosters transatlantic knowledge-sharing and networking among German-American and Californian business and tech communities through an online corporate database and 10-15 annual business events.
Arndt Schottelius, MD, PhD, Director Non-Clinical Drug Development, Genentech will provide insights to the decision making essential in taking a drug candidate from the research lab to drug development. Steps such as cost and risk analysis are discussed for making these crucial decisions on promising future cures.
A panel consisting of representatives of a Venture Capitalist, Jerini, a German Biotech company, and other local Bay Area Biotech companies will be discussing their criteria for funding drug development, presenting their process and expertise. This will provide some lively discussion post presentation.
Complimentary appetizers and drinks will be served.
GABA is a member-driven non-profit organization that fosters transatlantic knowledge-sharing and networking among German-American and Californian business and tech communities through an online corporate database and 10-15 annual business events.
read more
A panel consisting of representatives of a Venture Capitalist, Jerini, a German Biotech company, and other local Bay Area Biotech companies will be discussing their criteria for funding drug development, presenting their process and expertise. This will provide some lively discussion post presentation.
Complimentary appetizers and drinks will be served.
GABA is a member-driven non-profit organization that fosters transatlantic knowledge-sharing and networking among German-American and Californian business and tech communities through an online corporate database and 10-15 annual business events.
show less
Category:
Date/Times:
Kirkpatrick & Lockhart Nicholson Graham LLP
Four Embarcadero Center, 10th Floor, San Francisco, CA 94111
The Best Events
Every Week in Your Inbox
From Our Sponsors
UPCOMING EVENTS
Great suggestion! We'll be in touch.
Event reviewed successfully.